Do analysts recommend YI or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, YI or COSM?

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 111 $1.80B 0.02 -$9.65M -$1.60 N/A Cosmos Health $65.27M 0.52 -$19.15M -$0.64 N/A

Is YI or COSM more profitable?

111 has a net margin of -1.01% compared to Cosmos Health's net margin of -33.08%. 111's return on equity of 0.00% beat Cosmos Health's return on equity. Company Net Margins Return on Equity Return on Assets 111 -1.01% N/A -4.86% Cosmos Health -33.08% -56.88% -18.03%

Does the media favor YI or COSM?

In the previous week, Cosmos Health had 2 more articles in the media than 111. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for 111. 111's average media sentiment score of 1.05 beat Cosmos Health's score of 0.28 indicating that 111 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 111 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cosmos Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend COSM or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor COSM or MEDS?

In the previous week, Cosmos Health had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.28 beat Wellgistics Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Wellgistics Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RDGT or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, RDGT or COSM?

Ridgetech has higher revenue and earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.03 -$1.25M N/A N/A Cosmos Health $65.27M 0.52 -$19.15M -$0.64 N/A

Does the media refer more to RDGT or COSM?

In the previous week, Cosmos Health had 2 more articles in the media than Ridgetech. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for Ridgetech. Ridgetech's average media sentiment score of 0.79 beat Cosmos Health's score of 0.28 indicating that Ridgetech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cosmos Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer HKPD or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, HKPD or COSM?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $13.43M 0.14 -$1.14M N/A N/A Cosmos Health $65.27M 0.52 -$19.15M -$0.64 N/A

Do analysts prefer MCK or COSM?

McKesson presently has a consensus price target of $983.29, suggesting a potential upside of 4.87%. Given McKesson's stronger consensus rating and higher possible upside, research analysts clearly believe McKesson is more favorable than Cosmos Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.79 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, MCK or COSM?

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.27 $4.76B $37.37 25.09 Cosmos Health $65.27M 0.52 -$19.15M -$0.64 N/A

Is MCK or COSM more profitable?

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -33.08%. Cosmos Health's return on equity of -56.88% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Cosmos Health -33.08% -56.88% -18.03%

Does the media favor MCK or COSM?

In the previous week, McKesson had 39 more articles in the media than Cosmos Health. MarketBeat recorded 43 mentions for McKesson and 4 mentions for Cosmos Health. McKesson's average media sentiment score of 0.82 beat Cosmos Health's score of 0.28 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 23 Very Positive mention(s) 11 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Cosmos Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Cosmos Health (COSM) Competitors

$0.34 +0.02 (+6.84%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.33 0.00 (-1.16%)

As of 10/9/2026 07:36 PM Eastern

Compare

COSM vs. YI, MEDS, RDGT, HKPD, and MCK

Should you buy Cosmos Health stock or one of its competitors? Cosmos Health's main competitors and comparable companies include 111 (YI), Wellgistics Health (MEDS), Ridgetech (RDGT), Hong Kong Pharma Digital Technology (HKPD), and McKesson (MCK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Cosmos Health compare to 111?

111 (NASDAQ:YI) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

21.3% of 111 shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 43.9% of 111 shares are owned by insiders. Comparatively, 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$1.80B	0.02	-$9.65M	-$1.60	N/A
Cosmos Health	$65.27M	0.52	-$19.15M	-$0.64	N/A

111 has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.69, suggesting that its share price is 369% more volatile than the broader market.

111 has a net margin of -1.01% compared to Cosmos Health's net margin of -33.08%. 111's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
111	-1.01%	N/A	-4.86%
Cosmos Health	-33.08%	-56.88%	-18.03%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cosmos Health had 2 more articles in the media than 111. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for 111. 111's average media sentiment score of 1.05 beat Cosmos Health's score of 0.28 indicating that 111 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
111	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cosmos Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

111 beats Cosmos Health on 8 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Wellgistics Health?

Cosmos Health (NASDAQ:COSM) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

In the previous week, Cosmos Health had 2 more articles in the media than Wellgistics Health. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.28 beat Wellgistics Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Wellgistics Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cosmos Health has a beta of 4.69, meaning that its share price is 369% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.51, meaning that its share price is 451% less volatile than the broader market.

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.52	-$19.15M	-$0.64	N/A
Wellgistics Health	$23.34M	0.41	-$101.28M	-$46.13	N/A

12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by insiders. Comparatively, 29.1% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cosmos Health has a net margin of -33.08% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cosmos Health beats Wellgistics Health on 10 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Ridgetech has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.69, indicating that its stock price is 369% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ridgetech has higher revenue and earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A
Cosmos Health	$65.27M	0.52	-$19.15M	-$0.64	N/A

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by company insiders. Comparatively, 26.2% of Cosmos Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cosmos Health had 2 more articles in the media than Ridgetech. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for Ridgetech. Ridgetech's average media sentiment score of 0.79 beat Cosmos Health's score of 0.28 indicating that Ridgetech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cosmos Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Ridgetech has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Ridgetech's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cosmos Health	-33.08%	-56.88%	-18.03%

Summary

Ridgetech beats Cosmos Health on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Cosmos Health	-33.08%	-56.88%	-18.03%

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$13.43M	0.14	-$1.14M	N/A	N/A
Cosmos Health	$65.27M	0.52	-$19.15M	-$0.64	N/A

In the previous week, Cosmos Health had 2 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 4 mentions for Cosmos Health and 2 mentions for Hong Kong Pharma Digital Technology. Cosmos Health's average media sentiment score of 0.28 beat Hong Kong Pharma Digital Technology's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Neutral
Cosmos Health	Neutral

12.6% of Cosmos Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology has a beta of 2.57, suggesting that its stock price is 157% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.69, suggesting that its stock price is 369% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cosmos Health beats Hong Kong Pharma Digital Technology on 7 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to McKesson?

McKesson (NYSE:MCK) and Cosmos Health (NASDAQ:COSM) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.27	$4.76B	$37.37	25.09
Cosmos Health	$65.27M	0.52	-$19.15M	-$0.64	N/A

McKesson has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.69, meaning that its stock price is 369% more volatile than the broader market.

McKesson presently has a consensus price target of $983.29, suggesting a potential upside of 4.87%. Given McKesson's stronger consensus rating and higher possible upside, research analysts clearly believe McKesson is more favorable than Cosmos Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.79
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -33.08%. Cosmos Health's return on equity of -56.88% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Cosmos Health	-33.08%	-56.88%	-18.03%

In the previous week, McKesson had 39 more articles in the media than Cosmos Health. MarketBeat recorded 43 mentions for McKesson and 4 mentions for Cosmos Health. McKesson's average media sentiment score of 0.82 beat Cosmos Health's score of 0.28 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	23 Very Positive mention(s)	11 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Cosmos Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

85.1% of McKesson shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 26.2% of Cosmos Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

McKesson beats Cosmos Health on 12 of the 16 factors compared between the two stocks.

Get Cosmos Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COSM vs. The Competition

Export

Metric	Cosmos Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$31.64M	$9.81B	$7.16B	$13.21B
Dividend Yield	N/A	2.61%	2.53%	16.37%
P/E Ratio	-0.52	34.10	275.30	26.16
Price / Sales	0.52	4.87	635.97	107.53
Price / Cash	N/A	115.75	76.38	53.09
Price / Book	0.75	5.11	11.22	6.33
Net Income	-$19.15M	$315.68M	$3.50B	$382.15M
7 Day Performance	-11.61%	-0.38%	-0.89%	-1.40%
1 Month Performance	32.66%	-1.97%	-4.42%	-3.47%
1 Year Performance	-68.61%	12.76%	7.03%	1.18%

Cosmos Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COSM Cosmos Health	1.9425 of 5 stars	$0.34 +6.8%	N/A	-69.5%	$31.64M	$65.27M	N/A	163
YI 111	1.0444 of 5 stars	$3.09 -1.9%	N/A	-34.2%	$27.15M	$10.48B	N/A	1,063	Positive News
MEDS Wellgistics Health	0.29 of 5 stars	$3.07 -8.4%	N/A	-91.6%	$9.82M	$23.34M	N/A	31	Analyst Downgrade Gap Down
RDGT Ridgetech	0.6076 of 5 stars	$0.93 +4.9%	N/A	-99.5%	$3.22M	$132.16M	N/A	980
HKPD Hong Kong Pharma Digital Technology	1.4633 of 5 stars	$0.10 -0.7%	N/A	-91.4%	$1.68M	$13.43M	N/A	11	Positive News Short Interest Decrease Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COSM) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cosmos Health (COSM) Competitors

COSM vs. YI, MEDS, RDGT, HKPD, and MCK

How does Cosmos Health compare to 111?

Summary

How does Cosmos Health compare to Wellgistics Health?

Summary

How does Cosmos Health compare to Ridgetech?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Cosmos Health compare to McKesson?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cosmos Health (COSM) Competitors

COSM vs. YI, MEDS, RDGT, HKPD, and MCK

How does Cosmos Health compare to 111?

Do institutionals & insiders hold more shares of YI or COSM?

Which has preferable earnings and valuation, YI or COSM?

Which has more volatility & risk, YI or COSM?

Is YI or COSM more profitable?

Do analysts recommend YI or COSM?

Does the media favor YI or COSM?

Summary

How does Cosmos Health compare to Wellgistics Health?

Does the media favor COSM or MEDS?

Which has more risk & volatility, COSM or MEDS?

Which has preferable earnings and valuation, COSM or MEDS?

Do insiders and institutionals have more ownership in COSM or MEDS?

Is COSM or MEDS more profitable?

Do analysts recommend COSM or MEDS?

Summary

How does Cosmos Health compare to Ridgetech?

Which has more risk & volatility, RDGT or COSM?

Do analysts prefer RDGT or COSM?

Which has preferable valuation and earnings, RDGT or COSM?

Do institutionals & insiders hold more shares of RDGT or COSM?

Does the media refer more to RDGT or COSM?

Is RDGT or COSM more profitable?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Is HKPD or COSM more profitable?

Which has preferable earnings and valuation, HKPD or COSM?

Does the media favor HKPD or COSM?

Do insiders & institutionals have more ownership in HKPD or COSM?

Which has more risk and volatility, HKPD or COSM?

Do analysts prefer HKPD or COSM?

Summary

How does Cosmos Health compare to McKesson?

Which has better earnings and valuation, MCK or COSM?

Which has more risk & volatility, MCK or COSM?

Do analysts prefer MCK or COSM?

Is MCK or COSM more profitable?

Does the media favor MCK or COSM?

Do insiders and institutionals have more ownership in MCK or COSM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools